Cavazzoni Begins Putting Her Mark On FDA Drug Center With New Principal Deputy Position

Jacqueline Corrigan-Curay brings a broad array of policy experience, from trial design to real-world evidence to supply chain and post-market surveillance, to the CDER principal deputy director role, though US FDA is not yet able to articulate exactly what her promotion will entail.

FDA entrance sign 2016

The US Food and Drug Administration promoted Jacqueline Corrigan-Curay to principal deputy center director of the Center for Drug Evaluation and Research effective 4 July, a new position and the first senior leadership change since Patrizia Cavazzoni took over CDER in mid-April.

In Corrigan-Curay’s nearly five years as head of CDER’s Office of Medical Policy, she has worked on a wide range...

More from US FDA

More from Agency Leadership